关键词: Bendamustina Bendamustine Chlorambucil Chronic lymphocytic leukemia Chronic lymphoproliferative disorder Clorambucilo Fludarabina Fludarabine Leucemia linfocítica crónica Rituximab Síndrome linfoproliferativo crónico

Mesh : Antineoplastic Combined Chemotherapy Protocols / therapeutic use Blood Transfusion Combined Modality Therapy Comorbidity Disease Management Evidence-Based Medicine Hematologic Diseases / etiology therapy Hematopoietic Stem Cell Transplantation Humans Immunocompromised Host Leukemia, Lymphocytic, Chronic, B-Cell / complications diagnosis drug therapy surgery Opportunistic Infections / drug therapy etiology prevention & control Prognosis Recurrence Risk Factors Salvage Therapy Vaccination

来  源:   DOI:10.1016/j.medcli.2013.04.041   PDF(Sci-hub)

Abstract:
Chronic lymphocytic leukemia is the most common chronic lymphoproliferative disorder in Spain. The clinical management of this entity varies widely. Currently, in Spain, there are no national consensus guidelines, such as those published in other countries, to guide the diagnosis and treatment of this malignancy and the use of prognostic scores. This article reviews the current scientific literature and addresses issues on the diagnosis of chronic lymphocytic leukemia, the spread of the disease, the presence of comorbidities, the classification of prognostic scores, the common treatment regimens stratified by risk factors, and the management of complications associated with both the disease and its treatment, as well as the various controversies related to this entity. This document was drafted with the collaboration of national experts and aims to establish practical guidelines with their corresponding levels of evidence and grades of recommendation to guide the diagnosis, treatment and follow-up of patients with chronic lymphocytic leukemia.
摘要:
暂无翻译
公众号